Key result
Elevated von Willebrand factor levels predict major adverse cardiac events and clinical outcomes in patients with documented vascular disease, acute coronary syndromes, and atrial fibrillation.
Population
Patients with cardiovascular risk factors, documented vascular disease, acute coronary syndromes, atrial…
Design
Review
Authors
Loading...
Elevated von Willebrand factor may aid prognostication in vascular disease, ACS, and AF; leaves open its value as a therapeutic target.
Elevated von Willebrand factor levels serve as a predictive biomarker for adverse clinical outcomes in patients with established vascular disease and represent a promising target for novel antiplatelet therapies.
Paulinska et al. (2009) conducted a review in Vascular disease. von Willebrand factor (VWF) was evaluated. Elevated von Willebrand factor levels predict major adverse cardiac events and clinical outcomes in patients with documented vascular disease, acute coronary syndromes, and atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: